Why PCR is better than the rapid COVID-19 test?

Types of COVID-19 tests

There are two types of COVID-19 tests that are most common: polymerase chain reaction (PCR) tests and antigen tests, also known as rapid tests. Both tests require a sample, usually a nasal swab, to be taken from the patient.

How PCR test works

The PCR test requires a sample of ribonucleic acid (RNA) that is "amplified" with the help of laboratory techniques. Amplifying the RNA helps make tiny traces of the COVID-19 virus visible in the test sample. Even if you have a small amount of the virus in your body, the PCR test can detect it.

The PCR test does not change your genetic material - your DNA - in any way, and your test provider cannot do anything to your DNA other than tell you if you are positive for COVID-19.

Benefits of PCR tests

PCR tests are considered the gold standard when it comes to COVID-19 testing. PCR tests are more reliable and accurate because they test the specific genetic material of the virus, eliminating interference from other viruses.

The downside to PCR tests, is that results are not as quick as antigen tests. 

However, Anitoa's latest qPCR products have made it possible to complete a round of nucleic acid testing in less than 20 minutes. The efficiency of PCR tests has been greatly improved.

Handheld Multifunctional Fast qPCR Instrument

FQ1 qPCR System the lightest handheld, fast qPCR system that is compatible with standard qPCR assays. Suitable for nucleic acid detection of novel coronavirus, norovirus, influenza virus, malaria, and other pathogens.

Features of FQ1 qPCR System

Lightest hand-held qPCR instrument, only 1.18kg.

1 round of nucleic acid detection can be completed within 20 min.

A cost-effective configuration can be used for home testing.

External Android mobile phone can control the instrument.

4-well instrument but can be configured with up to 8 channels of fluorescence.

Professional Portable qPCR System Manufacturer - Anitoa

Anitoa is a professional R&D and manufacturing company of molecular diagnostic qPCR instruments and reagents, with independent intellectual property rights of core chip technology, optical technology, rapid heating, microfluidic control and supporting reagents and other patented technologies, so that the instruments developed by Anitoa are characterized by quick and easy small instruments, allowing the development of expensive and complex large PCR instruments into truly portable POCT products